RBRomy Enrica Baier

Romy Enrica Baier

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Romy Enrica Baier has a total of 4 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Principles of ribosome-associated protein quality control during the synthesis of CFTR

    by Tom Joshua Oldfield, Raquel Gonçalves Torres, Romy Enrica Baier, Robin Renn, Débora Broch Trentini

    Prolonged translational arrests caused by defective mRNAs activate the ribosome-associated protein quality control (RQC) pathway, which marks harmful incomplete proteins for degradation. Multipass transmembrane proteins have increased propensity to be targeted by the RQC, raising the question of whether problems in transmembrane domain insertion and assembly can also cause RQC-eliciting translational arrests. Here, we investigated RQC-mediated quality control of CFTR, a large transmembrane protein mutated in cystic fibrosis. Reporter assays showed that although a fraction of nascent CFTR expressed in HEK293 cells arrested during translation and activated the RQC, multiple interventions compromising CFTR folding and membrane insertion did not exacerbate this response. CFTR translation abortion was also largely unaffected by regulators of translation kinetics such as codon usage, the ribosome collision sensor GCN1, and the SRP ER targeting complex. We propose that the RQC can be triggered by the inherent difficulties in synthesizing transmembrane segments, resulting from their inappropriate interaction with the protein synthesis machinery. Our study uncovers and characterizes a novel physiological role for the RQC in dealing with elongation-arrested transmembrane proteins.

  • Open Access

    Principles of ribosome-associated protein quality control during the synthesis of CFTR

    by Tom Joshua Oldfield, Raquel Gonçalves Torres, Romy Enrica Baier, Robin Renn, Débora Broch Trentini

    Prolonged translational arrests caused by defective mRNAs activate the ribosome-associated protein quality control (RQC) pathway, which marks harmful incomplete proteins for degradation. Multipass transmembrane proteins have increased propensity to be targeted by the RQC, raising the question of whether problems in transmembrane domain insertion and assembly can also cause RQC-eliciting translational arrests. Here, we investigate RQC-mediated quality control of CFTR, a large transmembrane protein mutated in cystic fibrosis. Reporter assays show that although a fraction of nascent CFTR expressed in HEK293 cells arrests during translation and activates the RQC, multiple interventions compromising CFTR folding and membrane insertion do not exacerbate this response. CFTR translation abortion was also largely unaffected by regulators of translation kinetics such as codon usage, the ribosome collision sensor GCN1, and the SRP ER targeting complex. We propose that the RQC can be triggered by the inherent difficulties in synthesizing transmembrane segments, resulting from their inappropriate interaction with the protein synthesis machinery. Our study uncovers and characterizes a novel physiological role for the RQC in dealing with elongation-arrested transmembrane proteins.